The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin

Bibliographic Details
Main Authors:	Oblak, Irena, Cesnjevar, Monika, Anzic, Mitja, Hadzic, Jasna But, Ermenc, Ajra Secerov, Anderluh, Franc, Velenik, Vaneja, Jeromen, Ana, Korosec, Peter
Format:	Online
Language:	English
Published:	De Gruyter 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825341/

Similar Items

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
by: Oblak Irena, et al.
Published: (2016-03-01)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
by: Ratosa, Ivica, et al.
Published: (2015)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
by: Ratosa Ivica, et al.
Published: (2015-06-01)

Health-related quality of life assessed by the EORTC QLQ-C30 questionnaire in the general slovenian population
by: Velenik Vaneja, et al.
Published: (2017-04-01)

Long term outcome after combined modality treatment for anal cancer
by: Oblak, Irena, et al.
Published: (2012)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
by: Oblak, Irena, et al.
Published: (2014)

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia
by: Jeromen, Ana, et al.
Published: (2012)

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
by: Oblak, Irena, et al.
Published: (2013)

Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial
by: Velenik, Vaneja, et al.
Published: (2012)

Preoperative intensity-modulated chemoradiation therapy with simultaneous integrated boost in rectal cancer: 2-year follow-up results of phase II study
by: But-Hadzic Jasna, et al.
Published: (2018-02-01)

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
by: Oblak, Irena, et al.
Published: (2011)

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
by: Perpar Ana, et al.
Published: (2015-06-01)

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
by: Perpar, Ana, et al.
Published: (2015)

Black Anal Canal: Acute Necrosis
by: Barbeiro, Sandra, et al.
Published: (2016)

Gastrointestinal stromal tumor of the anal canal: an unusual presentation
by: Nigri, Giuseppe R, et al.
Published: (2007)

The Proliferative Capacity of the Lining Epithelium of the Anal Canal in Mice
by: O'Connor, R. J.
Published: (1956)

Anal Canal Duplication in an 11-Year-Old-Child
by: Van Biervliet, S., et al.
Published: (2013)

Metachronous tubulovillous and tubular adenomas of the anal canal
by: Nozawa, Hiroaki, et al.
Published: (2015)

Malignant melanoma of the anal canal: a case report
by: Barbus, Roxana, et al.
Published: (2009)

Plasmablastic Lymphoma of the Anal Canal in an HIV-Infected Patient
by: Chagas, Lucia Antunes, et al.
Published: (2014)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
by: Velenik, Vaneja, et al.
Published: (2011)

Relationship between anal symptoms and anal findings
by: Hans Georg Kuehn, Ole Gebbensleben, York Hilger, Henning Rohde
Published: (2009-01-01)

On Anal Fissure
Published: (1869)

Anal HIV DNA is associated with high-risk HPV genotypes in anal cytology specimens obtained for anal neoplasia screening
by: Shiramizu, Bruce, et al.
Published: (2012)

Anal canal carcinoma treatment results: the experience of a single institution
by: El-Haddad, Mostafa, et al.
Published: (2011)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
by: Kim, Kyung Hwan, et al.
Published: (2013)

Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experience
by: Brown, Elizabeth, et al.
Published: (2015)

Underwater endoscopic mucosal resection of a condyloma acuminatum of the anal canal
by: Hamada, Kenta, et al.
Published: (2017)

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy
by: Jones, Michael, et al.
Published: (2015)

Early Squamous Cell Carcinoma of the Anal Canal Resected by Endoscopic Submucosal Dissection
by: Tamaru, Yuzuru, et al.
Published: (2015)

IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal
by: Cendales, Ricardo, et al.
Published: (2014)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
by: Falk, Alexander Tuan, et al.
Published: (2014)

mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma
by: Matsunaga, Mototsugu, et al.
Published: (2016)

Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
by: Matsunaga, Mototsugu, et al.
Published: (2016)

Influence of rectal prolapse on the asymmetry of the anal sphincter in patients with anal incontinence
by: Damon, Henri, et al.
Published: (2003)

Anal Myolipoma: A New Benign Entity in Patients with an Anal Tumor?
by: Kang, Tae Young, et al.
Published: (2012)

The use of a simple anal sling in the management of anal incontinence
by: Devesa, José Manuel, et al.
Published: (2014)

How the anal gland orifice could be found in anal abscess operations
by: Paydar, Shahram, et al.
Published: (2015)

MRI for assessment of anal fistula
by: Torkzad, Michael R., et al.
Published: (2010)

Anal screening cytology
by: Leiman, Gladwyn
Published: (2005)